ArticleEClinicalMedicine2022

Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: A first-in-human open-label, randomized, dose-escalation, phase 1 clinical trial.

Katherine V Houser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.